Peter W. PENG, Author at MediaMedic

IDweek2023 | Antibiotic Resistance, Vaccines, and the Ongoing Global Health Challenge

By Peter W. PENG 2023.10.26

IDweek2023 Antibiotic Resistance, Vaccines, and the Ongoing Global Health Challenge As the world grapples with the prolonged challenges posed by the COVID-19 pandemic, it is crucial to recognize that other pressing global health issues, particularly antibiotic resistance, remain a serious concern. This issue is particularly significant in low- and middle-income countries where access to antibiotics is limited, and the inappropriate use of these drugs is rampant.

IDweek2023 | An In-depth Look at the Major Developments in Infectious Diseases

By Peter W. PENG 2023.10.26

IDweek2023 An In-depth Look at the Major Developments in Infectious Diseases Infectious diseases have been a significant concern to humanity for centuries. However, advancements in science and technology have significantly changed our understanding and management of these diseases. This article delves into ten impactful areas of basic and peri-clinical science, offering a comprehensive look into the future of infectious disease research and treatment.

IDweek2023 | “An Overview of Clinical ID Updates: From Trial Findings to CDC Insights”

By Peter W. PENG 2023.10.26

IDweek2023"An Overview of Clinical ID Updates: From Trial Findings to CDC Insights" The field of Clinical Infectious Diseases (ID) is perpetually evolving, with constant research and trials contributing to the development of new treatments and preventative measures for various infections. This article provides an overview of recent significant studies and CDC updates, as presented by leading ID expert, Dr. Patty Wright.

IDweek2023 | Advancements and Challenges in the Pursuit of an HIV Cure: An In-depth Review

By Peter W. PENG 2023.10.26

IDweek2023 Advancements and Challenges in the Pursuit of an HIV Cure: An In-depth Review Human Immunodeficiency Virus (HIV), a global health catastrophe, has demanded an urgent need for comprehensive therapeutic strategies. The search for an HIV cure has been an arduous journey, marked by a series of scientific breakthroughs and disappointments. However, current research proposes several potential strategies that could lead to HIV remission or even a cure. This extensive article aims to provide a thorough understanding of these strategies, focusing on the development of Broadly Neutralizing Antibody (bNAb)-inducing vaccines, the role of inflammasomes in HIV-infected cells, and the distinctive immune and viral features of post-treatment controllers.

IDweek2023 | Unveiling the Future of HIV Care: An In-Depth Analysis of Dr. Michelle Cespedes’ Presentation

By Peter W. PENG 2023.10.26

IDweek2023Unveiling the Future of HIV Care: An In-Depth Analysis of Dr. Michelle Cespedes' Presentation HIV/AIDS remains a significant global health issue, despite advancements in treatment and prevention methods. At the forefront of these advancements is Dr. Michelle Cespedes, a distinguished Professor of Medicine and Director of HIV Service at Mount Sinai Hospital. In her presentation during the ID Week, Dr. Cespedes presented a comprehensive overview of HIV care, discussing new data that could shape the future direction of HIV care. This article aims to provide an in-depth analysis of her presentation, focusing on the key takeaways and their implications for HIV care.

IDweek2023 | Assessing the Necessity of Dilated Retinal Exams for Pediatric Patients with Candidemia

By Peter W. PENG 2023.10.26

IDweek2023 Assessing the Necessity of Dilated Retinal Exams for Pediatric Patients with Candidemia Candidemia, a bloodstream infection caused by Candida species, poses a significant threat to pediatric patients, especially those with underlying conditions or compromised immune systems. The management of candidemia involves various aspects, including the assessment of potential ocular involvement. However, the necessity of performing dilated retinal exams in all pediatric patients with candidemia is a topic of debate. In this article, we will explore the arguments presented in the article titled "A Dilated Retinal Exam Should Not Be Completed in All Pediatric Patients With Candidemia – CON" by Dr. Ryan A Gise MD and evaluate the evidence supporting or refuting the routine use of dilated retinal exams in these patients.

IDweek2023 | PRO: The Imperative of Dilated Retinal Exams in All Pediatric Patients with Candidemia

By Peter W. PENG 2023.10.26

IDweek 2023 PRO: The Imperative of Dilated Retinal Exams in All Pediatric Patients with Candidemia Candidemia, a systemic fungal infection caused by Candida species, poses a substantial threat to pediatric patients. While the management of candidemia primarily revolves around the administration of appropriate antifungal therapy, the necessity of ophthalmologic evaluation, specifically dilated retinal exams, continues to be a subject of debate. In this comprehensive article, we advocate for the routine use of dilated retinal exams in all pediatric patients with candidemia, emphasizing the numerous potential benefits and addressing the concerns and complexities surrounding this practice.

IDweek2023 | Reevaluating the Necessity of Lumbar Punctures in Neonatal Gram-Negative Meningitis

By Peter W. PENG 2023.10.26

IDweek 2023 Reevaluating the Necessity of Lumbar Punctures in Neonatal Gram-Negative Meningitis Neonatal gram-negative meningitis is a devastating and potentially life-threatening infection that poses significant challenges to clinicians. The management of this condition typically involves prolonged antibiotic therapy, with the duration often determined by the results of lumbar punctures (LPs). However, recent discussions have raised important questions about the necessity of LPs in determining the end of therapy for neonatal gram-negative meningitis. In this article, we will delve into the arguments presented by Dr. Karen M. Puopolo, exploring the potential benefits and drawbacks of LPs in this context, and consider the broader implications of her work.

IDweek202 | The Importance of Performing Lumbar Puncture to Determine the End of Therapy in Neonatal Gram-negative Meningitis: Insights from Mano a Mano

By Peter W. PENG 2023.10.26

IDweek2023 The Importance of Performing Lumbar Puncture to Determine the End of Therapy in Neonatal Gram-negative Meningitis: Insights from Mano a Mano Neonatal gram-negative meningitis is a devastating infection that can lead to significant morbidity and mortality. The appropriate duration of antimicrobial therapy for this condition has been a topic of debate among experts in the field. In the Mano a Mano conference, Dr. Pablo J. Sanchez presented compelling evidence supporting the performance of lumbar puncture to determine the end of therapy in neonatal gram-negative meningitis. This article will delve into the key points presented by Dr. Sanchez, highlighting the importance of this diagnostic procedure in guiding treatment decisions and further exploring the nuances of neonatal gram-negative meningitis management.

IDweek2023 | Treatment Approach for Neonates with Bacteremic UTI: IV Therapy Only

By Peter W. PENG 2023.10.26

IDweek 2023 Treatment Approach for Neonates with Bacteremic UTI: IV Therapy Only Neonatal bacteremic urinary tract infection (UTI) is a life-threatening condition that demands immediate and effective treatment to safeguard the health and well-being of the affected infants. A crucial debate in the management of these cases revolves around the choice of treatment, specifically whether neonates with bacteremic UTI should be exclusively treated with intravenous (IV) therapy or if alternative treatment approaches, potentially involving oral therapy, can be considered. This article delves deeper into the arguments and evidence surrounding the use of IV therapy as the primary treatment modality for neonates with bacteremic UTI.